Kits Eyecare (TSE:KITS) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Kits Eyecare Ltd. has successfully completed a secondary offering of common shares, resulting in the sale of over 1.1 million shares owned by key stakeholders, including Roger Hardy, at $10.15 per share. The offering, which did not financially benefit KITS directly, was facilitated by Canaccord Genuity and Beacon Securities. Alongside the offering, a concurrent sale of shares by the spouse of Sabrina Liak was also completed, with insiders continuing to hold approximately 75% of the company’s shares.
For further insights into TSE:KITS stock, check out TipRanks’ Stock Analysis page.
Trending Articles:
- “The No. 1 Destination for the Most Talented Artists”: Netflix Stock (NASDAQ:NFLX) Notches Up as the Duffer Brothers Consider Jumping Ship
- “Breakthrough EVs”: Ford Stock (NYSE:F) Notches Up on New Battery Details
- “An Equity Stake”: Intel Stock (NASDAQ:INTC) Surges as U.S. Government May Buy In With CHIPS Act Money